Overview

Who is accountable for each alliance, and what does it mean to be accountable?

How do we optimize our business processes for partnering?

Over the last few years, Amgen has tackled these key questions head-on through a cross functional
effort to significantly enhance its alliance management capabilities.

Learn about Amgen's journey to improve alliance management. This session will explain how Amgen gathered data from partners and Amgen's own employees to identify where Amgen performs well as a partner and where it requires improvement.

The session will go on to describe how Amgen leveraged this data as the basis for change and then took action to enhance its alliance management capabilities by:

Clarifying the single point of accountability for each alliance

Differentiating the roles and responsibilities of team leads, alliance managers, and project managers with respect to alliances

Building and enhancing key best practice capabilities, such as health check methodology and new alliance launch processes

Optimizing some of Amgen's core business processes for partnering

The session will conclude with an early look into how these changes are being received across the organization.

About the Speakers:

Casey Capparelli
Global Product General Manager in Oncology
Amgen

Casey Capparelli, global product general manager in oncology at Amgen, is an experienced biopharma
executive with over 20 years of industry experience and international cross-functional expertise. Casey is currently accountable for global product strategy, execution and team performance for two of Amgen's oncology assets. Prior to his current role, Casey served as the head of alliance and integration management where he was accountable for managing Amgen's global portfolio of alliances, joint ventures and outlicenses as well as leading Amgen's integration readiness capability. Over the course of his career, Casey successfully led multiple domestic and international acquisition integrations.

He has led Amgen's portfolio management and stage gate governance process and served as chief of staff for the head of research and preclinical development. He has experience leading broad organization-wide change initiatives and has extensive scientific and drug development experience gained through multiple roles early in his career.

Casey holds a Master of Business Administration from Pepperdine University and a Bachelor of Science degree in Biochemistry from the University of New Hampshire.

Eric Hyllengren
Executive Director, Business Development
Head of Alliance Management
Amgen

Eric Hyllengren, executive director of business development, leads the alliance management team at Amgen and brings over 15 years of industry experience to the role. He is accountable for managing Amgen's global portfolio of alliances, joint ventures and outlicenses and is responsible for embedding partnership excellence throughout the organization.

Prior to his current role, Eric spent two years leading the corporate finance team responsible for developing the annual operating, capital, and long-range financial plans. In addition, Eric worked closely with senior leadership on resource allocation decisions, transformation initiatives, and quarterly earnings call preparations. In this role, Eric also led both the financial systems and partnership finance teams and assumed the role of assistant CFO of our Kirin-Amgen joint venture.

Prior to this role, Eric held positions in investor relations, corporate finance, corporate business analysis, and operations finance. Before coming to Amgen in 2003, Eric worked in various financial management roles at AT&T, the Walt Disney Company, and a privately held high-tech company.

Eric holds an MBA from the Northwestern University Kellogg School of Management and a BBA in finance and Russian from the University of Notre Dame.